Benzenecarboxamide analogs of fluoroquinolones (BCFQs). Antibacterial activity and SAR studies

Letters in Drug Design and Discovery

Volumn 3, Issue 2, 2006, Pages 108-111

  Nieto, M J ^a,b   Alovero, F L ^a   Manzo, R H ^a   Mazzieri, M R ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Antimicrobial; Benzenecarboxamides; Ciprofloxacin; Fluoroquinolones; Norfloxacin; SAR

Indexed keywords

7 [4 (4 AMINOBENZOYL) 1 PIPERACINIYL] 1 CYCLOPROPYL 6 FLUORO 1,4 DIHYDRO 4 OXO QUINOLINE 3 CARBOXYLIC ACID; 7 [4 (4 AMINOBENZOYL) 1 PIPERACINIYL] 1 ETHYL 6 FLUORO 1,4 DIHYDRO 4 OXO QUINOLINE 3 CARBOXYLIC ACID; 7 [4 (4 NITROBENZOYL) 1 PIPERACINIYL] 1 CYCLOPROPYL 6 FLUORO 1,4 DIHYDRO 4 OXO QUINOLINE 3 CARBOXYLIC ACID; 7 [4 (4 NITROBENZOYL) 1 PIPERACINIYL] 1 ETHYL 6 FLUORO 1,4 DIHYDRO 4 OXO QUINOLINE 3 CARBOXYLIC ACID; 7 [4 (BENZOYL) 1 PIPERACINIYL] 1 CYCLOPROPYL 6 FLUORO 1,4 DIHYDRO 4 OXO QUINOLINE 3 CARBOXYLIC ACID; 7 [4 (BENZOYL) 1 PIPERACINIYL] 1 ETHYL 6 FLUORO 1,4 DIHYDRO 4 OXO QUINOLINE 3 CARBOXYLIC ACID; AMIDE; ANTIINFECTIVE AGENT; CARBONYL DERIVATIVE; CIPROFLOXACIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DESIGN; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

EID: 33645873003     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018006775789702     Document Type: Article

References (18)

1. Strahilevitz, J. and Hooper, D.C. Antimicr. Ag. Chemother. 2005, 49(5), 1949-1956.
2. Pan, X.-S.; Hamlyn, P.; Talens-Visconti, R.; Alovero, F.; Manzo, R.; Fisher, L. Antimicr. Ag. Chemother. 2002, 46 (8), 2498-2506.
3. Hooper, D.C.; Rubinstein, E. (Ed.). Quinolone Antimicrobial Agents. ASM Press American Society for Microbiology. Washington, USA, 2003.
4. Shen, L.; Mitscher, L.; Sharma, P.; O'Donnell, T.; Chu, D.; Cooper, C.; Rossen, T.; Pernet, A. Biochemistry 1989, 28, 3886-3894.
5. Manzo, R.H.; Allemandi, D.A.; Perez J.D. (1995) U.S. Patent 5, 395-936.
6. Allemandi, D.; Alovero, F.; Manzo, R. J. Antimicr. Chemother. 1994, 34, 261-265.
7. Alovero, F.; Nieto, M.; Mazzieri, M.; Then, R.; Manzo, R. Antimicr. Agents Chemother. 1998, 42 (6), 1495-1498.
8. Nieto, M.; Alovero, F.; Manzo, R.; Mazzieri, M. Eur. J. Med. Chem. 1999, 34, 209-214.
9. Nieto, M.; Alovero, F.; Manzo, R.; Mazzieri, M. Eur. J. Med. Chem. 2005, 40, 361-369.
10. Alovero, F.; Barnes, A.; Nieto, M.; Mazzieri, M.; Manzo, R. J. Antimicr. Chemother. 2001, 48 (5), 709-712.
11. Alovero, F.; Pan, X.-S.; Morris, J.; Manzo, R.; Fisher, L. Antimicr. Ag. Chemother. 2000, 44 (2), 320-325.
12. Wermuth C.G. (ed.) The Practice of Medicinal Chemistry. Academic Press, London, 1996.
13. National Committer for Clinical Laboratory Standards (NCCLS). Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Tentative Standard, M7-A2, National Committee for Clinical Laboratory Standards, Villanove, PA, 2000.
14. Llorente, B.; Leclerc, F.; Cedergren, R. Bioorg. Med. Chem. 1996, 4(1), 61-71.
15. Ohta, M.; Koga, H. J. Med. Chem. 1991, 34, 131-139.
16. Domagala, J. J. Antimicr. Chemother . 1994, 33 (4), 685-706.
17. Peterson, L. Clin. Infect. Dis. 2001, 33 (Suppl. 3), 180-186.
18. Koga, H.; Itoh, A.; Murayama, S.; Suzue, S.; Irikura. T. J. Med. Chem. 1980, 23, 1358-1363.